Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program. (Q54462541)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program. |
scientific article |
Statements
Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program (English)
Pierre Karakiewicz
Alfonsus J M van den Eertwegh
Sevil Bavbek
Sergio Bracarda
Amit Bahl
Yen-chuan Ou
Dennis Kim
Ashok Panneerselvam
Oezlem Anak
Viktor Grünwald
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference